Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
M-02胶囊在健康受试者中多次给药的安全性、耐受性及药动学研究
[Translation] Safety, Tolerance and Pharmacokinetics of M-02 Capsules in Healthy Subjects after Multiple Dosing
主要目的:评价M-02胶囊在健康受试者中多次口服给药的安全性与耐受性。次要目的:评价M-02胶囊在健康受试者中多次给药的药代动力学(PK)特征。
[Translation] OBJECTIVE: To evaluate the safety and tolerability of multiple oral administration of M-02 capsules in healthy subjects. Secondary objective: To evaluate the pharmacokinetic (PK) profile of M-02 capsules in healthy subjects after multiple dosing.
M-02胶囊在健康受试者中单次给药的安全性、耐受性及药动学研究
[Translation] Safety, Tolerability and Pharmacokinetics of M-02 Capsules in Healthy Subjects after Single Dosing
主要目的:评价M-02胶囊在健康受试者中单次口服给药的安全性与耐受性。
次要目的:评价M-02胶囊在健康受试者中单次给药的药代动力学(PK)特征。
[Translation] OBJECTIVE: To evaluate the safety and tolerability of single oral administration of M-02 capsules in healthy subjects.
Secondary objective: To evaluate the single-dose pharmacokinetic (PK) profile of M-02 capsules in healthy subjects.
100 Clinical Results associated with Shanghai Hanmai Biomedical Technology Co Ltd
0 Patents (Medical) associated with Shanghai Hanmai Biomedical Technology Co Ltd
100 Deals associated with Shanghai Hanmai Biomedical Technology Co Ltd
100 Translational Medicine associated with Shanghai Hanmai Biomedical Technology Co Ltd